Pacific Biosciences Of California | PACB - Debt


Pacific Biosciences Of California reported $892M in Debt for its fiscal quarter ending in September of 2023.





Debt Change Date
Agilent USD 3.35B 55M Sep/2025
Bruker USD 2.01B 426.8M Sep/2025
Danaher USD 18.42B 1.56B Dec/2025
General Electric Aerospace USD 20.49B 344M Dec/2025
Illumina USD 2.58B 22M Sep/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Pacific Biosciences Of California USD 892M 201K Sep/2023
Quidel USD 2.84B 51.1M Sep/2025
Revvity USD 3.37B 5.86M Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Standard Biotools USD 27.39M 1.23M Sep/2025
Thermo Fisher Scientific USD 35.68B 451M Sep/2025
Waters USD 1.49B 52.2M Sep/2025